JP2019509281A - 組成物および治療方法 - Google Patents

組成物および治療方法 Download PDF

Info

Publication number
JP2019509281A
JP2019509281A JP2018545179A JP2018545179A JP2019509281A JP 2019509281 A JP2019509281 A JP 2019509281A JP 2018545179 A JP2018545179 A JP 2018545179A JP 2018545179 A JP2018545179 A JP 2018545179A JP 2019509281 A JP2019509281 A JP 2019509281A
Authority
JP
Japan
Prior art keywords
terbinafine
composition
range
derivative
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018545179A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019509281A5 (enExample
Inventor
ジョン リデン
ジョン リデン
クリスティン カロライン リデン
クリスティン カロライン リデン
デイヴィッド クック
デイヴィッド クック
Original Assignee
ブルーベリー セラピューティクス リミテッド
ブルーベリー セラピューティクス リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ブルーベリー セラピューティクス リミテッド, ブルーベリー セラピューティクス リミテッド filed Critical ブルーベリー セラピューティクス リミテッド
Publication of JP2019509281A publication Critical patent/JP2019509281A/ja
Publication of JP2019509281A5 publication Critical patent/JP2019509281A5/ja
Priority to JP2023148797A priority Critical patent/JP2023182607A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Optics & Photonics (AREA)
  • Emergency Medicine (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP2018545179A 2016-03-25 2017-03-24 組成物および治療方法 Pending JP2019509281A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023148797A JP2023182607A (ja) 2016-03-25 2023-09-13 組成物および治療方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1605127.8A GB201605127D0 (en) 2016-03-25 2016-03-25 Composition and methods of treatment
GB1605127.8 2016-03-25
PCT/GB2017/050852 WO2017163091A1 (en) 2016-03-25 2017-03-24 Composition and methods of treatment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023148797A Division JP2023182607A (ja) 2016-03-25 2023-09-13 組成物および治療方法

Publications (2)

Publication Number Publication Date
JP2019509281A true JP2019509281A (ja) 2019-04-04
JP2019509281A5 JP2019509281A5 (enExample) 2020-04-16

Family

ID=56027421

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018545179A Pending JP2019509281A (ja) 2016-03-25 2017-03-24 組成物および治療方法
JP2023148797A Pending JP2023182607A (ja) 2016-03-25 2023-09-13 組成物および治療方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023148797A Pending JP2023182607A (ja) 2016-03-25 2023-09-13 組成物および治療方法

Country Status (6)

Country Link
US (1) US20200206160A1 (enExample)
EP (1) EP3432867A1 (enExample)
JP (2) JP2019509281A (enExample)
CN (2) CN109562077A (enExample)
GB (1) GB201605127D0 (enExample)
WO (1) WO2017163091A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201710491D0 (en) * 2017-06-30 2017-08-16 Blueberry Therapeutics Ltd Composition and methods of treatment
EP4041839A4 (en) 2019-10-08 2023-10-11 Hallux, Inc. ONYCHOMYCOSIS TREATMENT COMPOSITIONS AND METHODS

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013515742A (ja) * 2009-12-23 2013-05-09 ヌーボ リサーチ インコーポレイテッド 高浸透性テルビナフィン製剤
JP2015516455A (ja) * 2012-05-14 2015-06-11 アルミラル・ソシエダッド・アノニマＡｌｍｉｒａｌｌ， Ｓ．Ａ． 局所用医薬組成物
JP2016507540A (ja) * 2013-02-07 2016-03-10 ポリケム・エスエイ 爪真菌症を治療するための局所用抗真菌薬組成物
JP2016536271A (ja) * 2013-09-25 2016-11-24 ブルーベリー セラピューティクス リミテッド 抗真菌局所組成物および処置の方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030147925A1 (en) * 1998-09-11 2003-08-07 Samuel P. Sawan Topical dermal antimicrobial compositions, methods for generating same, and monitoring methods utilizing same
JP2014501286A (ja) * 2010-12-29 2014-01-20 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー 真菌感染症および他の適応症に対する処置の経皮的送達
GB201511799D0 (en) 2015-07-06 2015-08-19 Blueberry Therapeutics Ltd Composition and methods of treatment

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013515742A (ja) * 2009-12-23 2013-05-09 ヌーボ リサーチ インコーポレイテッド 高浸透性テルビナフィン製剤
JP2015516455A (ja) * 2012-05-14 2015-06-11 アルミラル・ソシエダッド・アノニマＡｌｍｉｒａｌｌ， Ｓ．Ａ． 局所用医薬組成物
JP2016507540A (ja) * 2013-02-07 2016-03-10 ポリケム・エスエイ 爪真菌症を治療するための局所用抗真菌薬組成物
JP2016536271A (ja) * 2013-09-25 2016-11-24 ブルーベリー セラピューティクス リミテッド 抗真菌局所組成物および処置の方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
テルビナフィン塩酸塩外用液１％「トーワ」医薬品インタビューフォーム, JPN6021004908, 2015, pages 1 - 26, ISSN: 0004443999 *

Also Published As

Publication number Publication date
CN117379391A (zh) 2024-01-12
US20200206160A1 (en) 2020-07-02
WO2017163091A1 (en) 2017-09-28
JP2023182607A (ja) 2023-12-26
GB201605127D0 (en) 2016-05-11
EP3432867A1 (en) 2019-01-30
CN109562077A (zh) 2019-04-02

Similar Documents

Publication Publication Date Title
JP7028836B2 (ja) 抗真菌局所組成物および処置の方法
JP7320559B2 (ja) 組成物および治療方法
Vikas et al. Mechanistic insights of formulation approaches for the treatment of nail infection: conventional and novel drug delivery approaches
JP2023182607A (ja) 組成物および治療方法
Varshosaz et al. Development of bioadhesive chitosan gels for topical delivery of lidocaine
JP2007534764A (ja) 抗真菌薬物送達
JP2025000870A (ja) ポリマー及びテルビナフィンから形成されるナノ粒子
Verma et al. An emanation of nail lacquer in the management of nail disorders: a comprehensive review
BR112021003746A2 (pt) sistema de distribuição transdermal de fármacos

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200304

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200304

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20210120

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210216

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210512

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210715

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210816

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220106

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220406

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220510

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220810

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221004

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221227

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230306

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230530

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230913

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20230925

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20230929

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250909